SpectroCor

Tissue spectrometry for real-time monitoring of myocardial oxygenation during open-heart surgery and transplantation — the surgeon sees directly how well the heart is being protected instead of inferring it. Founded by paediatric heart surgeon Tommi Pätilä (also a founder of Koite Health) and optical tissue-spectroscopy engineer Kalle Kotilahti; the oximetry was validated against a tissue haemoglobin phantom in a peer-reviewed 2025 study. In Aalto University's innovation portfolio.

The row

Sector

Medtech & Digital Health

Stage

Pre-revenue — No sales yet

Location

Helsinki

Founded

2020

Business ID

3123776-4 · Finnish trade register

Funding

Business Finland Deep Tech Accelerator (2023); backing from Aalto University, SPARK Finland and Aalto Start-Up Center. No disclosed venture round

Links

Where this sits on the map

SpectroCor is one of 33 companies in Medtech & Digital Health. The others:

How this row was decided

Every row on this map is checked by hand against the trade register and the company's own material, and placed in the sector that best describes its business or its technology. Service firms and consultancies are left out, however advanced the technology they work with — the test is where the revenue comes from. Only funding figures the company or its investor has published are shown. The full rules are on the landscape ↗